Hilterapia® and hand arthropathy from systemic lupus erythematosus: a new study

07 August 2020 - Research -
Share

A recent study - “Efficacy of high-intensity laser therapy on arthropathy of the hands in patients with systemic lupus erythematosus: a double-blinded, randomized controlled trial” – conducted on a sample of 50 patients affected by systemic lupus erythematosus with arthropathy to the hands confirms the efficacy of treatment with Hilterapia®.

Divided into two equally numbered groups, the patients (women between 30 and 50) respectively underwent Hilterapia® therapy combined with routine therapy (heat therapy, stretching and reinforcing exercises) and placebo laser with a similar routine program. After three sessions every 7 days for a total of 8 weeks, statistically significant differences were seen in grip strength, swelling, joint pain and VAS in favour of the group treated with Hilterapia®.

In conclusion, the addition of Hilterapia® to the routine therapeutic program can lead to a more effective improvement of the assessed parameters for patients with arthropathy to the hands compared with the routine therapeutic program on its own.

You might also be interested in ...

See all articles

blog - 12/02/2019
Laser Therapy influences In the medical field, laser is used for surgical (laser surgery) and therapeutic (laser therapy) applications. In particular, laser therapy is a physical therapy which can...
news - 30/01/2019
“Effect of a physiotherapy rehabilitation program on knee osteoarthritis in patients with different pain intensities”: this is the title of the research which aimed to examine the effects of a...
Efficacy of HILT on arthropathy of the hands
Research
N.M. Abdel-Aal, K.M. Ali, H.M. Eladl  Clinical Rehabilitation, Jul 8:269215520941059. doi: 10.1177/0269215520941059, 2020 Objective: To determine the efficacy of high-intensity laser therapy (...
Press - 04/02/2021
iDNES.cz, the online version of the national daily newspaper MF DNES, reproposes the news of MLS® Laser Therapy’s effectiveness in treating pneumonia caused by COVID-19.
Press - 22/01/2021
Novuslight.com, an American portal of technology which focuses on light, picks up the news of the positive results obtained by Doctor Scott Sigman (an orthopaedic surgeon in Massachusetts) when using...
Press - 21/01/2021
After viewing the successful results obtained by Doctor Scott Sigman (an orthopaedic surgeon in Massachusetts) when using MLS® Laser Therapy for a clinical trial to treat interstitial pneumonia...